home / stock / nxgl / nxgl news

NXGL News and Press, NexGel Inc From 01/18/24

Stock Information
Company Name: NexGel Inc
Stock Symbol: NXGL
Market: NASDAQ
Website: nexgel.com
Menu
NXGL NXGL Quote NXGL Short NXGL News NXGL Articles NXGL Message Board
Get NXGL Alerts

News, Short Squeeze, Breakout and More Instantly...
NXGL - NEXGEL to Present at The Microcap Conference, January 30th through February 1st

LANGHORNE, Pa., Jan. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that Adam Lev...
NXGL - NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

LANGHORNE, Pa., Jan. 09, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications,...

NXGL - NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

LANGHORNE, Pa., Dec. 11, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications,...

NXGL - NEXGEL expands health and wellness portfolio with acquisition of psoriasis skincare line

2023-12-05 08:31:37 ET More on NEXGEL NEXGEL, Inc. (NXGL) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on NEXGEL Historical earnings data for NEXGEL Financial information for NEXGEL For further details see: NEXGEL expands h...
NXGL - NEXGEL Acquires Kenkoderm Psoriasis Skincare Line

Acquisition expands NEXGEL’s health and wellness consumer product portfolio Synergies support optimization of marketing and supply chain operations to drive revenue growth and margins Kenkoderm for the trailing twelve months is profitable and expected to be immediately accr...

NXGL - NEXGEL, Inc. (NXGL) Q3 2023 Earnings Call Transcript

2023-11-17 14:27:02 ET NEXGEL, Inc. (NXGL) Q3 2023 Results Conference Call November 13, 2023 04:30 PM ET Company Participants Valter Pinto - MD, KCSA Strategic Communications Adam Levy - CEO Adam Drapczuk - CFO Conference Call Participants Naz Rahman ...

NXGL - NEXGEL GAAP EPS of -$0.10 beats by $0.02, revenue of $1.2M in-line

2023-11-13 17:27:01 ET More on NEXGEL NEXGEL, Inc. (NXGL) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on NEXGEL Historical earnings data for NEXGEL Financial information for NEXGEL For further details see: NEXGEL GAAP EPS ...
NXGL - NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

Gross profit margin improved sequentially to 28.2% in Q3 as compared to 15.0% in Q2 LANGHORNE, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-con...

NXGL - Expected US Company Earnings on Monday, November 13th, 2023

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

NXGL - NEXGEL to Report Third Quarter 2023 Financial Results on November 13th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hy...
Previous 10 Next 10